Thus, an independent prognostic predictor of PAAD is TSC22D2 high expression, and TSC22D2 expression was also higher in pancreatic cancer tissues/cells than in normal tissues/cells. This evidence concerns the gene TSC22D2 and pancreatic adenocarcinoma.